Growing tumor models from gastrointestinal neuroendocrine tumor surgery
Part of Cancer, Digestive system clinical trials.
This study takes tumor tissue from people having surgery for a certain type of gut or pancreas cancer (neuroendocrine tumors). The tissue is used to grow tiny 3D models called organoids in the lab, which can help researchers learn more about the tumor and find better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You need a diagnosis of a neuroendocrine tumor (NEN) in the stomach, intestines, or pancreas, confirmed by a biopsy or special scan.
- You must be having surgery to remove the tumor and enough tissue will be available for research.
- You must give written permission to take part.
- You cannot have received chemotherapy for this tumor before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to make 3D models in the lab that look like your specific tumor. The goal is to better understand pancreatic neuroendocrine tumors and find personalized treatments.
This study looks at the nutritional health of people with a type of digestive tumor called a neuroendocrine tumor. It aims to understand how these tumors affect nutrition, which could help doctors improve care.
This is a registry study that collects medical information from adults with neuroendocrine tumors (NETs) that start in the digestive organs. It helps researchers understand these cancers better and may support future studies.
This study looks at how tumor and patient factors affect treatment response in well-differentiated GEP-NENs (neuroendocrine tumors of the digestive system). It may help doctors understand which treatments work best for people like you.
This study uses a special lab model made from tumor tissue taken during a planned standard cancer surgery. It tests how well the lab model can represent your cancer, which may help researchers improve future treatments.
This study looks at whether a special PET scan (called 68Ga-SSTR) can better show if a neuroendocrine tumor has spread to nearby lymph nodes before surgery. If you've already had this scan, joining could help researchers learn more about its accuracy for your type of tumor.
Hear when a new Gastro-entero-pancreatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.